Baohua Xie

Discovery of Novel Bicyclic Phenylselenyl-Containing Hybrids: An Orally Bioavailable, Potential, and Multiacting Class of Estrogen Receptor Modulators against Endocrine-Resistant Breast Cancer

Xiangping Deng, Baohua Xie, Qiuzi Li et al. · Journal of Medicinal Chemistry · 2022 · 30 citations · Full text

Discovery of a Novel Class of PROTACs as Potent and Selective Estrogen Receptor α Degraders to Overcome Endocrine-Resistant Breast Cancer <i>In Vitro</i> and <i>In Vivo</i>

Baohua Xie, Zhinang Yin, Zhiye Hu et al. · Journal of Medicinal Chemistry · 2023 · 29 citations · Full text

Enantioselective synthesis of novel pyrano[3,2-<i>c</i>]chromene derivatives as AChE inhibitors<i>via</i>an organocatalytic domino reaction

Jie Zheng, Ming He, Baohua Xie et al. · Organic & Biomolecular Chemistry · 2017 · 27 citations

Identification of Novel Dual-Target Estrogen Receptor α Degraders with Tubulin Inhibitory Activity for the Treatment of Endocrine-Resistant Breast Cancer

Xiangping Deng, Xiaofei Deng, Wentao Ning et al. · Journal of Medicinal Chemistry · 2023 · 20 citations · Full text

Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer

Yubo Wang, Jian Min, Xiangping Deng et al. · Acta Pharmaceutica Sinica B · 2023 · 19 citations · Full text